USA Truck Inc. (USAK) Jumps 6.56% on January 21

Equities Staff |

USA Truck Inc. (USAK) was among the biggest gainers on the Russell 2000 for Thursday January 21 as the stock popped 6.56% to $14.62, representing a gain of $0.9 per share. Some 34,299 shares traded hands on 401 trades, compared with an average daily volume of 59,813 shares out of a total float of 10.14 million. The stock opened at $13.78 and traded with an intraday range of $14.93 to $13.51.

After today's gains, USA Truck Inc. reached a market cap of $148.31 million. USA Truck Inc. has had a trading range between $32.14 and $11.58 over the last year, and it had a 50-day SMA of $17.68 and a 200-day SMA of $20.70.

The stock has a P/E Ratio of 13.7.

USA Truck Inc is a transportation and logistics service provider. The Company transports commodities throughout the continental United States and into and out of portions of Canada. It also transports general commodities into and out of Mexico.

USA Truck Inc. is based out of Van Buren, AR and has some 2,800 employees. Its CEO is John R. Rogers.

For a complete fundamental analysis analysis of USA Truck Inc., check out Equities.com’s Stock Valuation Analysis report for USAK. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets

XY Find It

Founded by serial entrepreneur Arie Trouw, XY Findables follows a single guiding principle: customers should never lose anything important again. With over 50,000 users around the world, more than 100,000…

D-Wave

D-Wave Systems is the first quantum computing company. Its mission is to integrate new discoveries in physics, engineering, manufacturing, and computer science into breakthrough approaches to computation to help solve…